Coping Strategies, Anxiety and Depression in OCD and Schizophrenia: Changes during COVID-19

Rosa‐Alcázar, Ángel; Parada-Navas, José L.; García-Hernández, María Dolores; Martínez-Murillo, Sergio; Olivares-Olivares, Pablo J.; Alcázar, Ana Isabel Rosa

doi:10.3390/brainsci11070926

Cited by 15 publications

(12 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nevertheless, some of the positive impacts (i.e. not having to leave home during the lockdown or meeting other people) might indeed reflect a tendency to avoid social interactions, as previously observed in individuals with schizophrenia during the pandemic ( Rosa-Alcázar et al, 2021 ). Karanci et al (2019) found that negative social interactions were an important source of burden for Turkish people with schizophrenia and that they cope with this by avoiding social contexts.…”

Section: Discussionmentioning

confidence: 66%

How did the Covid-19 pandemic affect individuals with schizophrenia from Turkey?

Karancı

İkizer

Aldemir

et al. 2022

Int J Soc Psychiatry

View full text Add to dashboard Cite

Background: Serious mental illness, including schizophrenia, have been shown to be associated with psychosocial vulnerabilities in the face of adverse events. While individuals with schizophrenia might undergo many psychosocial difficulties during the COVID-19 pandemic, they might also not be affected, or report increased subjective well-being. This suggests that it is important to understand diverse impacts and further understand the unique experiences. Methods: To capture how the pandemic affected them and how they handled the challenges if there were any in the initial and more recent phases of the pandemic, 18 individuals with schizophrenia living in Turkey were interviewed. Results: Thematic analysis of interviews resulted in four superordinate themes for both time points. Three themes related to the impact of the pandemic (i.e. burdens of COVID-19, positive impacts of COVID-19, no impact of COVID-19) indicated that they shared a number of challenges with the general population. Themes about the positive impacts and no impact also replicated the previous findings in this clinical population. One last theme named as facilitators of coping implied that the participants tried to deal with the burdens by using available resources, adapt to the changes in their daily living, and benefit from social interaction and support. Conclusions: To conclude, people with schizophrenia seem to be coping with challenges posed by the pandemic with diverse strategies and they seem to even experience psychological growth alongside with negative impacts. The individualized needs and potential for growth have pivotal implications for the management of the illness during the pandemic.

show abstract

Section: Discussionmentioning

confidence: 66%

How did the Covid-19 pandemic affect individuals with schizophrenia from Turkey?

Karancı

İkizer

Aldemir

et al. 2022

Int J Soc Psychiatry

View full text Add to dashboard Cite

show abstract

“…15165 cases of community-dwelling patients with schizophrenia in this survey all had mild to severe anxiety and depression, which is supported by previous research. Compared to the control group, community-dwelling patients with schizophrenia experienced signi cantly higher scores in HADS-A and HADS-D during the covid-19 pandemic [14]. Moreover, 40.8% of community-dwelling patients with schizophrenia (n = 76) reported depression and 32.9% reported anxiety [15].…”

Section: Discussionmentioning

confidence: 92%

“…However, the report did not analyze anxiety and depressive symptoms separately in patients with schizophrenia during the outbreak. A Spanish study showed that compared to the control group, community-dwelling patients with schizophrenia (n = 42) experienced signi cantly higher scores in Hospital Anxiety and Depression Scale Anxiety (HADS-A) and Hospital Anxiety and Depression Scale Depression (HADS-D) during the COVID-19 pandemic [14]. Moreover, 40.8% of community-dwelling patients with schizophrenia (n = 76) reported depression and 32.9% reported anxiety [15].…”

Section: Introductionmentioning

confidence: 99%

Anxiety and depression in community-dwelling patients with schizophrenia in China during the COVID-19 pandemic

Chen

Sun

Zhu

et al. 2022

Preprint

View full text Add to dashboard Cite

Background The 2019 Corona Virus Disease (COVID-19) poses a huge challenge to the global public health. People with schizophrenia living in communities urgently need effective interventions to help them adjust to life and work, but they have not received enough attention. This study aims to assess the prevalence of anxiety and depression symptoms in community-dwelling patients with schizophrenia in China during the epidemic, and to explore possible influencing factors. Methods Using a cross-sectional survey, we collected 15165 questionnaires. Assessments included subjects’ demographic information, knowledge of COVID-19-related information, sleep status, anxiety symptoms, depressive symptoms, and other accompanying illnesses. The Chinese versions of the 7-item Generalized Anxiety Disorder (GAD-7) and the 9-item Patient Health Questionnaire (PHQ-9) were used to evaluate the depression and anxiety of patients. Results Moderate to severe anxiety accounted for 16.9%, and the percentage of moderate and above depression was 34.9%. T-test showed that females with schizophrenia had a significantly higher score of GAD-7 and PHQ-9 than males with schizophrenia (t=-2.03, P = 0.042; t=-3.27, P = 0.001), and patients without other accompanying long-standing diseases (t = 4.18, P < 0.001; t = 6.86, P < 0.001), not understanding COVID-19 (t = 8.17, P<0.001; t = 2.29, P = 0.022) had lower GAD-7 and PHQ-9 scores. ANOVA showed that participants aged from 30 to 39 (F = 2.8, ,P = 0.014), with higher educational levels (F = 4.0, ༌P = 0.007) scored higher on GAD-, ༌and patients with better sleep(F = 158.8, ༌P < 0.001; F = 284.0, ༌P < 0.001), having a simple knowledge of COVID-19 (F = 93.19, P<0.001; F = 95.30, P<0.001) had lower GAD-7 and PHQ-9 scores. Bivariate regression analysis indicated that participants aged 30–39 and 40–49 positively predicted anxiety, whereas only patients aged 30–39 years were positively predictive of depression. Participants with poor sleep, other long-standing diseases, knowing the COVID-19 pandemic were more likely to experience anxiety and depression. Conclusion Patients aged from 30 to 39, with poor sleep, other accompanying long-standing diseases, knowing the COVID-19 pandemic were potential factors of depression and anxiety. We need to strengthen psychological intervention for patients with schizophrenia.

show abstract

“…Der Großteil der Studien beschreibt negative Auswirkungen der COVID-19-Pandemie auf das Leben von Menschen mit Schizophrenie [9][10][11][12][13][14][15][16][17]. Andere Studien konnten bei unterschiedlichen untersuchten Faktoren keine Verschlechterung feststellen [18][19][20][21].…”

Section: Was Ist Bereits Bekannt?unclassified

Auswirkungen der COVID-19-Pandemie auf das Leben von Menschen mit Schizophrenie

Baumann¹

2023

PPH

View full text Add to dashboard Cite

COVID-19 beeinflusst die psychische Gesundheit vieler Menschen. Vor allem Menschen mit psychischen Erkrankungen gelten als Risikogruppe, da sie Belastungen besonders intensiv erfahren. Im Rahmen einer Masterarbeit wurden Menschen mit Schizophrenie in Leitfadeninterviews zu ihren Ressourcen, Problemen und Wünschen befragt. Denn nur, wenn wir mit den betroffenen Personen direkt sprechen und ihnen Raum geben sich zu äußern, kann ihre Versorgung langfristig verbessert werden und Recovery gelingen.

show abstract

Coping Strategies, Anxiety and Depression in OCD and Schizophrenia: Changes during COVID-19

Cited by 15 publications

References 29 publications

How did the Covid-19 pandemic affect individuals with schizophrenia from Turkey?

How did the Covid-19 pandemic affect individuals with schizophrenia from Turkey?

Anxiety and depression in community-dwelling patients with schizophrenia in China during the COVID-19 pandemic

Auswirkungen der COVID-19-Pandemie auf das Leben von Menschen mit Schizophrenie

Contact Info

Product

Resources

About